A detailed history of Lecap Asset Management LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lecap Asset Management LTD holds 46,068 shares of BMY stock, worth $2.66 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
46,068
Previous 56,787 18.88%
Holding current value
$2.66 Million
Previous $2.36 Billion 1.07%
% of portfolio
0.51%
Previous 0.51%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$39.66 - $51.75 $425,115 - $554,708
-10,719 Reduced 18.88%
46,068 $2.38 Billion
Q2 2024

Jul 23, 2024

BUY
$40.25 - $52.99 $605,199 - $796,757
15,036 Added 36.01%
56,787 $2.36 Billion
Q1 2024

Apr 25, 2024

BUY
$47.98 - $54.4 $699,164 - $792,716
14,572 Added 53.61%
41,751 $2.26 Billion
Q4 2023

Jan 29, 2024

BUY
$48.48 - $57.85 $1.32 Million - $1.57 Million
27,179 New
27,179 $1.39 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Lecap Asset Management LTD Portfolio

Follow Lecap Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lecap Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lecap Asset Management LTD with notifications on news.